Phytocemicals of Cannabis - Nisa, Alim-un-;Yaseen, Rubab
16,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
payback
8 °P sammeln
  • Broschiertes Buch

Several medications derived from cannabis that has been refined and standardized are now accessible for medical use. However, the use of herbal cannabis for medical purposes is still quite debatable. The active element in cannabis, cannabidiol (CBD), and a couple of synthetic cannabis-like medications, dronabinol, and nabilone, are examples of products that have received FDA approval. While some European nations authorize the use of herbal cannabis for therapeutic purposes, it's forbidden in the UK. However, it does permit the prescription of nabiximols, a cannabis-based medication.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Several medications derived from cannabis that has been refined and standardized are now accessible for medical use. However, the use of herbal cannabis for medical purposes is still quite debatable. The active element in cannabis, cannabidiol (CBD), and a couple of synthetic cannabis-like medications, dronabinol, and nabilone, are examples of products that have received FDA approval. While some European nations authorize the use of herbal cannabis for therapeutic purposes, it's forbidden in the UK. However, it does permit the prescription of nabiximols, a cannabis-based medication.
Autorenporträt
Dr.Asma Saeed is working as Chief Scientific Officer and Ms. Alim-un-Nisa is workings as Principal Scientific Officer in the Food and Biotechnology Research Centre, PCSIR Laboratories Complex, Lahore, Pakistan. They are involved in conducting research projects for existing and new product development.